REVIEWS |
|
S.B. Erofeeva (1, 3), E.P. Smirnova (2, 3)
Review of clinical guidelines for the treatment of children with confirmed coronavirus infection COVID-19: a clinical pharmacologist’s view
|
10-14 |
|
V.A. Bulgakova (1), E.N. Kareva (2, 3), L.R. Selimzyanova (3, 4), T.E. Privalova (2, 4)
Antihistamines in pediatric practice: what we need to know?
|
15-23 |
|
A.N. Surkov (1, 2, 3)
Algorithm for the treatment of functional constipation in children: modern concepts
|
24-30 |
|
A.L. Zaplatnikov (1), A.A. Girina (2), I.V. Lepiseva (3), V.I. Svintsitskaya (1)
Topical bacterial lysates in pediatric practice
|
31-37 |
|
|
A.R. Savkina (1), M.A. Kareva (2), M.A. Melikyan (2)
Long-acting somatostatin analogues in the treatment of children with congenital hyperinsulinism. Literature review
|
38-41 |
ORIGINAL ARTICLES |
|
L.V. Osidak, E.G. Golovacheva, O. I. Afanasyeva, E.A. Smorodintseva, V.V. Gonchar, E.V. Obraztsova, E.S. Goncharova, K.A. Stolyarov
Treatment of ARVI in young children
|
42-49 |
|
N.V. Breslav (1), E.S. Kirillova (1), I.V. Kukes (2), E.I. Burtseva (1)
Antiviral activity of Tantum Verde And its active substance benzydamine hydrochloride against influenza virus in vitro
|
50-54 |
|
L.M. Alimbarova (1), I.V. Kukes (2)
Evaluation of the antiviral activity of benzydamine hydrochloride and its finished dosage form Tantum® Verde against herpes simplex virus types 1 and 2
|
55-62 |
|
P.B. Khishtilova, D.F. Sergienko
Effect of SFTPD gene rs721917 polymorphism on the course and outcomes of bronchopulmonary dysplasia in children
|
63-67 |
|
K.D. Ermolenko (1), N.P. Boldyreva (2), E.I. Ermolenko (2)
Probiotics in the treatment of acute intestinal infections in children
|
68-73 |
|
E.A. Pyreva (1), M.V. Gmoshinskaya (1), E.A. Olyushina (2), N.V. Kotova (2), A.I. Safronova (1), S.Yu. Mkoyan (1), I.V. Aleshina (1)
Nutritional features of modern schoolchildren of different age groups
|
74-80 |
|
I.A. Averina, D.F. Sergienko
The course of chronic lung diseases in children in terms of VDR gene FokI polymorphism
|
81-85 |
|
K. D. Ermolenko (1), N.V. Gonchar (1, 2)
Possibilities of prevention and drug therapy of gastroenterological pathology after viral intestinal infections in children
|
86-91 |
|
|
A.A. Tarasova (1), M.P. Kostinov (2, 3)
Relevance of the use of a combined hexavalent vaccine against pertussis, diphtheria, tetanus, hemophilus influenzae, poliomyelitis and hepatitis B
|
92-98 |
|
E.P. Smirnova (1, 2), S.B. Erofeeva (2, 3)
Features of the use of non-steroidal anti-inflammatory drugs in the treatment of fever: emphasis on safety
|
99-102 |
|
L.N. Mazankova (1), T.A. Chebotareva (1), S.G. Gorbunov (1), A.A. Khamatova (1), E.N. Kaurova (2), M.N. Ermakova (2), E.V. Rudikova (2), N.P. Valts (2)
Differentiated approach to the etiological diagnosis of acute diarrhea in children in the epidemic season 2020: clinical cases
|
103-107 |
Русский
